Context (Background): Metabolic syndrome or Insulin resistance syndrome is a cluster of metabolic abnormalities, where people are obese and have hypertension, dyslipidemia, back elevated glucose levels and a multifactorial disorder associated with the development of cardiovascular, neurological, immunological, renal and endocrine disease. Metabolic syndrome (MetS) is a condition harbouring a group of metabolic abnormalities where insulin resistance (IR) plays a major role. Aims: The aim of our study is to evaluate the need for thyroid dysfunction and the prevalence of MetS in males and females. Materials and Methods: A retrospective study with a total no of 100 patients both genders included who satisfied the criteria of the International diabetic federation of Metabolic Syndrome were randomly allocated to the study. The study was conducted between September 2019 to September 2022.